Risk factors for significant fibrosis in non-obese Asian patients with NAFLD

被引：0
|
作者：
Jeong, Jae Yoon [1 ]
Cho, Ju-Yeon [2 ]
Kim, Jung Hee [3 ]
Cho, Yong Kyun [4 ]
Kim, Byung Ik [4 ]
Sohn, Won [4 ]
机构：
[1] Natl Med Ctr, Seoul, South Korea
[2] Chosun Univ Hosp, Gwangju, South Korea
[3] Hallym Univ, Dongtan Sacred Heart Hosp, Chunchon, South Korea
[4] Sungkyunkwan Univ, Kangbuk Samsung Hosp, Sch Med, Seoul, South Korea
来源：
JOURNAL OF HEPATOLOGY | 2023年 / 78卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
THU-469
引用
收藏
页码：S637 / S637
页数：1
相关论文
共 50 条
  • [1] Distinct signatures of gut microbiome and metabolites associated with significant fibrosis in non-obese NAFLD
    Lee, Giljae
    You, Hyun Ju
    Bajaj, Jasmohan S.
    Joo, Sae Kyung
    Yu, Junsun
    Park, Seoyeon
    Kang, Hyena
    Park, Jeong Hwan
    Kim, Jung Ho
    Lee, Dong Hyeon
    Lee, Seonhwa
    Kim, Won
    Ko, GwangPyo
    NATURE COMMUNICATIONS, 2020, 11 (01)
  • [2] Distinct signatures of gut microbiome and metabolites associated with significant fibrosis in non-obese NAFLD
    Giljae Lee
    Hyun Ju You
    Jasmohan S. Bajaj
    Sae Kyung Joo
    Junsun Yu
    Seoyeon Park
    Hyena Kang
    Jeong Hwan Park
    Jung Ho Kim
    Dong Hyeon Lee
    Seonhwa Lee
    Won Kim
    GwangPyo Ko
    Nature Communications, 11
  • [3] Clinical features and risk factors associated with NAFLD in non-obese type 2 diabetes patients
    Ichikawa, Takeshi
    Oi, Itaru
    Fujino, Masayuki A.
    HEPATOLOGY, 2017, 66 : 1139A - 1139A
  • [4] Non-Obese Patients With NAFLD Have More Advanced NASH Than Obese NAFLD Patients
    Danford, Christopher J.
    Sanchez, Jorge
    Choi, Yuri
    Zheng, Hui
    Misdraji, Joseph
    Masia, Ricard
    Corey, Kathleen E.
    Chung, Raymond T.
    GASTROENTEROLOGY, 2016, 150 (04) : S1144 - S1144
  • [5] Cardiovascular risk factors in non-obese PCOS patients
    Garcia-Gamon, M.
    Romeu, M.
    Monzo, A.
    Montanana, V.
    Perez-Calvo, A.
    Tresguerres, J.
    Romeu, A.
    HUMAN REPRODUCTION, 2010, 25 : I84 - I85
  • [6] A Comparison of Non-Obese Non-Alcoholic Fatty Liver Disease (NAFLD) and Obese NAFLD Patients
    Mitchell, Brittany
    Aggarwal, Manik
    McCullough, Arthur
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2020, 115 : S1703 - S1704
  • [7] HUMAN GUT MICROBIOME AND STOOL METABOLITES PREDICT SIGNIFICANT FIBROSIS IN BIOPSY-PROVEN NON-OBESE NAFLD
    Kim, Won
    Lee, Giljae
    You, Hyun Ju
    Bajaj, Jasmohan S.
    Joo, Sae Kyung
    Lee, Dong Hyeon
    Ko, GwangPyo
    HEPATOLOGY, 2019, 70 : 1153A - 1153A
  • [8] Predictors of Nonalcoholic Steatohepatitis and Significant Fibrosis in Non-Obese Population
    Kim, Won
    Kim, Donghee
    Joo, Saekyoung
    Lee, Dong Hyeon
    Jung, Yong Jin
    HEPATOLOGY, 2018, 68 : 989A - 990A
  • [9] A NON-INVASIVE METHOD FOR ESTIMATING THE SEVERITY OF LIVER STEATOSIS AND THE RISK OF FIBROSIS IN NON-OBESE TYPE 2 DIABETES PATIENTS WITH NAFLD
    Mitrovic, B.
    Gluvic, Z.
    Klisic, A.
    Obradovic, M.
    Macut, D.
    Tomasevic, R.
    Isenovic, E. R.
    ACTA ENDOCRINOLOGICA-BUCHAREST, 2022, 18 (04) : 480 - 487
  • [10] Prevalence and Risk Factors of Non-Alcoholic Fatty Liver Disease (NAFLD) in Non-Obese Patients with Schizophrenia: A Retrospective Study
    Yi, Wenying
    Wu, Haibo
    Fu, Weibin
    Feng, Huimei
    Huang, Jie
    Li, Haijing
    Song, Zhen
    Chen, Yuwei
    Zheng, Yingjun
    She, Shenglin
    DIABETES METABOLIC SYNDROME AND OBESITY, 2024, 17 : 841 - 849
12345